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Background: Chest wall syndrome (CWS), the main cause of chest pain in primary care practice, is most often an
exclusion diagnosis. We developed and evaluated a clinical prediction rule for CWS.
Methods: Data from a multicenter clinical cohort of consecutive primary care patients with chest pain were used
(59 general practitioners, 672 patients). A final diagnosis was determined after 12 months of follow-up. We used the
literature and bivariate analyses to identify candidate predictors, and multivariate logistic regression was used to
develop a clinical prediction rule for CWS. We used data from a German cohort (n = 1212) for external validation.
Results: From bivariate analyses, we identified six variables characterizing CWS: thoracic pain (neither retrosternal
nor oppressive), stabbing, well localized pain, no history of coronary heart disease, absence of general practitioner’s
concern, and pain reproducible by palpation. This last variable accounted for 2 points in the clinical prediction rule,
the others for 1 point each; the total score ranged from 0 to 7 points. The area under the receiver operating
characteristic (ROC) curve was 0.80 (95% confidence interval 0.76-0.83) in the derivation cohort (specificity: 89%;
sensitivity: 45%; cut-off set at 6 points). Among all patients presenting CWS (n = 284), 71% (n = 201) had a pain
reproducible by palpation and 45% (n = 127) were correctly diagnosed. For a subset (n = 43) of these correctly
classified CWS patients, 65 additional investigations (30 electrocardiograms, 16 thoracic radiographies, 10 laboratory
tests, eight specialist referrals, one thoracic computed tomography) had been performed to achieve diagnosis. False
positives (n = 41) included three patients with stable angina (1.8% of all positives). External validation revealed the
ROC curve to be 0.76 (95% confidence interval 0.73-0.79) with a sensitivity of 22% and a specificity of 93%.
Conclusions: This CWS score offers a useful complement to the usual CWS exclusion diagnosing process. Indeed,
for the 127 patients presenting CWS and correctly classified by our clinical prediction rule, 65 additional tests and
exams could have been avoided. However, the reproduction of chest pain by palpation, the most important
characteristic to diagnose CWS, is not pathognomonic.
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When evaluating a patient with chest pain, the initial
diagnostic step aims to rule out a life-threatening cause
such as acute coronary syndrome or a pulmonary em-
bolism [1]. However, the most common aetiology of
chest pain in primary care practice is chest wall syn-
drome (CWS) [2], a benign source of chest pain* Correspondence: alexandre@ronga.net
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reproduction in any medium, provided the orlocalized to the anterior chest wall and caused by a mus-
culoskeletal disorder [2,3]. Recent studies have shown
that its incidence in primary care ranges from 20.4% to
46.6% [2,4-6].
CWS remains a diagnostic challenge [7]. Due to the
absence of a consensus for diagnosing CWS, the diagno-
sis is usually obtained after the exclusion of other causes
of chest pain, but this approach is time-consuming and
requires important resources that could be directed else-
where. Clinical signs related to CWS have been shownLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[1], suggesting thata clinical prediction rule may help to
identify patients with CWS. Although it is critical to ex-
clude a life-threatening condition, reaching a diagnosis
also seems to be very important for patients [8]. The
need to develop non-invasive algorithms for primary
care patients complaining of chest pain has been men-
tioned previously [9]. A literature review did not un-
cover a previously reported, validated clinical prediction
rule for CWS [2,3,10-18], although a recent study
described a four-point algorithm (localized muscle ten-
sion, stinging pain, pain reproducible by palpation and
absence of cough) that can contribute to the diagnosis of
CWS [10]. The aim of the present study was to develop
and validate a clinical prediction rule for diagnosing
CWS based on medical history and physical examination
alone.
Methods
Design overview
We used data from the TOPIC (Thoracic Pain in Com-
munity) cohort, a multicentre cohort of primary care
patients with chest pain, to develop a clinical prediction
rule for CWS. We then analyzed data from a German
study (the initial Marburg chest pain study, designed and
conducted independently of the TOPIC cohort), a multi-
centre cohort of primary care patients with acute chest
pain, to validate our rule. The original purpose of both
studies was to investigate the characteristics of chest pain
in primary care practice. Methods for both studies have
been established previously and described (fully or par-
tially) in various publications [2,6,10,19-30]. Later in the
text, the TOPIC cohort will be referred as the “derivation
cohort” and the German study as the “validation cohort”.
Setting and participants: derivation cohort
General practitioners (GPs) in 58 independent medical
offices and the medical residents of one university hos-
pital outpatient department in Western Switzerland
(counted as one additional practice) participated in the
TOPIC study. All consecutive patients presenting with
anterior chest pain (as a main or minor medical com-
plaint) over a three-to-nine-week period (median length,
five weeks) from March to May 2001 were included. Par-
ticipating physicians had an average duration of experi-
ence in private practice of 12 years (range, 1–24 years).
They received detailed information on the study and
were trained to complete the forms during a meeting.
The study protocol was approved by the Ethical Com-
mittee of the Canton of Vaud (Prot. 41/2000) [20].
Setting and participants: validation cohort
Between October 2005 and July 2006, all attending
patients with anterior chest pain (aged 35 years and over;n=1249) were consecutively recruited to this study by 74
participating GPs in the state of Hesse, Germany. The re-
cruitment period lasted 12 weeks for each practice.
Patients were excluded when chest pain had lasted for
one month or had already been noted by the primary care
physician. The overall study protocol was approved by
the Ethical Committee of the Faculty of Medicine, Uni-
versity of Marburg [6].
Outcome and variables
CWS is defined as a benign cause of chest pain localized
to the anterior chest wall and caused by a musculoskel-
etal disorder [2,3]. CWS is coded in the International
Classification of Disease (ICD 10 R07.4) as “Anterior
chest-wall pain not otherwise specified,” as well as in the
International Classification of Primary Care (ICPC)
under L04 as “Pain attributed to chest wall/pain attribu-
ted to musculoskeletal system” and under A11 as “Chest
pain not otherwise specified” [31,32]. CWS includes
fibromyalgia but excludes traumas, metastasis, and re-
ferred pain from the back. CWS encompasses various
syndromes and clinical entities, such as costochondritis,
costosternal syndrome, Tietze’s syndrome, chondrocostal
pain, slipping rib syndrome, intercostal pain, left chon-
drocostal syndrome, left pectoral syndrome, and sternal
syndrome [2].
A literature review was performed for two purposes.
First, we wished to determine whether any clinical pre-
diction rules for CWS had been generated for primary
care. Bösner et al. developed a simple score containing
four determinants [10], but it has not been validated in
an external cohort. Second, we wished to identify rele-
vant variables used to describe CWS for collection from
patient histories and physical examinations (Table 1
[2,3,10-18]). The following key words were used to
search PubMed: "Chest Pain"[Mesh] AND ("Thoracic
Wall"[Mesh] OR "Musculoskeletal System"[Mesh] OR
"Musculoskeletal Diseases"[Mesh]) AND "Diagnosis"
[Mesh]. In addition to the variables identified in the
literature, those that appeared clinically relevant were
selected for inclusion in this study.
Data sources: derivation cohort
Information was recorded regarding GP activity, age, and
experience, as well as patient basic characteristics, key
past history, pain characteristics, and associated symp-
toms. The first part of the case report form (CRF)
included 70 questions on history and clinical examin-
ation of chest pain. With the exception of age, all vari-
ables were dichotomized. Information about additional
medical tests, the suspected diagnosis, and treatment de-
cision was also recorded [20]. Follow-up data were
obtained during additional consultations three and 12
months after the initial contact. CRFs included
Table 1 Variables indicating chest wall syndrome (ambiguous variables in bold)
Medical history
Thoracic pain described as Sharp/stinging Trivial
Aching Lasting more than 5 min
Not squeezing nor oppressive Localized to one small area of the chest
Pressure-like Left or median left part of the chest wall
Of varying intensity Unilateral
Relieving factors Decrease movement Nitroglycerine don’t relieve
Cessation of movement Rest don’t relieve
Change in position Quiet breathing
Physical activity
Associated/triggering factors Exertion Physical activities that stress the upper body
Not exercise-induced No consistency according to exercise
Certain activities Unaccustomed physical activity
At rest Trunk movement/movement
Coughing Certain position
Absence of cough Antecedent illness with coughing
Repeated minor trauma Deep breathing
History of rhumatoid arthritis Psychic stress
Physical examination
Palpation Pain is reproducible Chest wall tenderness
Pain may not be reproducible Localized muscle tension
Paraspinal tenderness
Tests Horizontal flexion of arm Spinal motion palpation restriction
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assays, referrals to specialists, admissions to emergency
wards, hospitalizations, and health events during the
follow-up period. The initial suspected diagnosis was
confirmed or modified during follow-up; we used the
GP’s final diagnosis at 12 months as the reference diag-
nosis. When it was not possible to confirm the diagnosis,
or if the diagnosis at 12 months was missing, the patient
was contacted for further information through his GP. If
the patient could not be contacted, the diagnosis at three
months was retained. This method is not believed to be
perfect, but is the best acceptable solution for studies in
family practice settings [33]. The GP’s diagnosis was clas-
sified by the research team as CWS if it matched any-
thing under this umbrella term as defined in the ICPC
(see above, in section on outcome and variables).
Data sources: validation cohort
As described previously [6], GPs took a standardized his-
tory and performed a physical examination according to a
CRF. They also recorded their preliminary diagnoses, inves-
tigations, and management related to the patients’ chest
pains. Patients were contacted by phone six weeks and six
months after the index consultation. Study assistants
blinded to the clinical data already recorded inquired aboutthe course of the patients’ chest pain as well as treatments
including hospitalization and drugs. Discharge letters from
specialists and hospitals were requested from GPs.
Protection against bias: derivation cohort
All completed forms were sent to the study coordination
centre. A set of predefined criteria was used for data entry
checks, and the GPs were contacted to resolve inconsisten-
cies or to complete missing data. Double data entry was
used to identify transcription errors. Data cleaning and val-
idation was performed by a group of physicians experi-
enced in research. When the diagnosis reported by the GP
was not consistent throughout the follow-up year, the final
diagnosis for chest pain was discussed and approved by a
group of clinicians who were not aware of the aim of this
study. Quality control of the reported diagnosis was done
using patients up to date medical records at the GP’s office
for a random ten percent sample of the included patients.
No inconsistencies were identified.
Protection against bias: validation cohort
As described previously [6], participating practices were
recruited from a network of research practices asso-
ciated with the University of Marburg Department of
General Practice. The importance of recruiting every
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lihood of ischemic heart disease was emphasized to the
participating GPs. Practices were visited at 4-week inter-
vals to check CRFs, recruitment logs, and compliance
with study procedures. Random audits of the routine
documentation of participating practices were imple-
mented to identify cases of chest pain not included in
the study. After six months, a reference panel consisting
of one cardiologist, one GP, and one member of the re-
search staff at the Department of Family Medicine
reviewed the baseline and follow-up data of each patient.
Analyzing all the information gathered during the
follow-up period (results of further investigations, letters
from specialists, hospital discharge reports, etc.), the
panel decided on the most likely medical condition re-
sponsible for each patient’s chest pain at baseline.Statistical analysis
Using data from the derivation cohort alone, bivariate
logistic regression analysis was performed to detect vari-
ables associated with CWS. Odds ratios (ORs) ≥ 2.0 were
retained as potentially relevant for the multivariate ana-
lysis. To prevent overfitting related to colinearity, weFigure 1 Flow chart of derivation cohort: patient recruitment
and follow-up data. GPs = general practitioners.explored the advantages of combining similar factors.
For example, the variables “well localized pain (medical
history)” and “well localized pain (physical examination)”
were combined to create the variable “well localized pain
(medical history and/or physical examination).” Variables
were retained if their combination significantly improved
the multivariate model compared to the use of either
factor alone in the model (P-value of likelihood ratio test
between models < 0.05). According to the regression
coefficients in the multivariate analysis, weights (points)
were attributed to each factor in order to build a score.
The area under the receiver operating characteristic
(ROC) curve was measured as an indicator of the dis-
criminatory power of the score. We arbitrarily set the
cut-off for specificity at ≥ 85%. Other researchers have
used this cut-off for specificity [34].
The retained score was then applied to the validation
cohort for external validation. Clinical signs that were
not reported by the physician were considered absent by
default. A second analysis was performed by multiple
imputation for missing values of the key variable (pain
reproducible by palpation). In the validation cohort, the
best proxy for "pain well localized" was "localized muscle
tension". The extent of pain from other tissues could not
be taken into account. Area under the ROC curve, sen-
sitivity, and specificity were calculated in both cohorts.
All analyses were performed with StataCorp. 2009 Statis-
tical Software (release 11.0, StataCorp, College Station,
Texas, USA).
Results
Study population (derivation cohort)
A total of 664 patients with chest pain, aged 18 years
and over, were included in the derivation cohort (22
patients were included and followed by the University
Hospital Outpatient Department). Of these, 618 (93%)
completed a 12-month follow-up with an available diag-
nosis. For the 46 cases with no formal diagnosis at 12Table 2 Number, age and sex of derivation and
validation cohorts: patients with CWS and whole study
population at baseline
Study Baseline characteristics CWS
patients
Study
population
Derivation cohort Number of patients (%) 284 (44.1) 644 (100.0)
Mean age (range), years 50.5 (18–90) 55.4 (18–95)
Sex : male patients,
number (%)
136 (47.9) 307 (47.7)
Validation cohort Number of patients (%) 565 (46.6) 1212 (100.0)
Mean age (range), years 58 (35–90) 59 (35–93)
Sex: male patients,
number (%)
235 (41.6) 534 (44.1)
CWS chest wall syndrome.
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However, diagnoses were available for 26 of these
patients, with the diagnosis known before death orTable 3 Odds of having chest wall syndrome (CWS) for all
potential predictors and availability of each variable for
external validation. Final variables retained for the
clinical prediction rule are given in bold
Simple variables OR CWS
vs. others
(95% CI)
P-value Available for
external
validation
Trivial (history and
physical examination)
9.11 (5.52-15.03) <0.001 No
Pain reproducible
by palpation
6.47 (4.58-9.15) <0.001 Yes
No history of coronary
heart disease
5.12 (2.88-9.12) <0.001 Yes
Pain not retrosternal 5.08 (2.94-8.78) <0.001 Yes
Absence of general
practitioner’s concern
4.96 (2.79-8.84) <0.001 Yes
Pain well localized (history) 2.65 (1.91-3.67) <0.001 Yes
Pain superficial 2.48 (1.72-3.56) <0.001 No
Pain well localized
(physical examination)
2.46 (1.78-3.39) <0.001 Yes
Pain not oppressive 2.37 (1.69-3.31) <0.001 Yes
Pain related to position 2.13 (1.48-3.06) <0.001 No
Stabbing pain 2.11 (1.38-3.24) 0.001 Yes
Pain related to movement 2.06 (1.42-3.01) <0.001 Yes
Pain is not burning 1.62 (0.94-2.77) 0.081 Yes
Pain is not spread 1.52 (1.03-2.25) 0.037 No
Pain is not deep 1.30 (0.95-1.78) 0.100 No
Pain related to breathing 1.19 (0.83-1.71) 0.344 Yes
Absence of stressful stimulus 1.15 (0.72-1.82) 0.560 No
Intermittent pain 0.95 (0.69-1.29) 0.723 Yes
Absence of patient’s concern 0.92 (0.67-1.26) 0.613 Yes
Radiating pain 0.78 (0.51-1.20) 0.255 Yes
Pain is accompanied
by cough
0.83 (0.56-1.24) 0.361 Yes
Pain related to cough 0.57 (0.37-0.89) 0.013 No
Combined variables{
Pain neither retrosternal
nor oppressive
3.11 (2.24-4.33) <0.001 Yes
Pain well localized
(history and/or
physical examination)
3.07 (2.17-4.35) <0.001 Yes
Pain related to mechanical
factors (position
and/or movement)
2.56 (1.85-3.56) <0.001 No
Pain is accompanied by
digestive symptoms}
0.54 (0.35-0.85) 0.01 No
}Gastroesophageal reflux and/or odynodysphagia and/or dysphagia and/or
epigastralgia.
{Association of two simple variables.
CWS chest wall syndrome, OR odd ratio.retained at the 3-month follow-up. Therefore, the popu-
lation analyzed in this study consisted of 644 patients
(Figure 1), 47.7% male, with mean age 55.4 years (range
18–95 years). CWS was diagnosed in 284 cases (Table 2).
Chest pain was reproducible by palpation for 299/644
(46.4%) patients of the derivation cohort and for 201/284
(70.1%) of the CWS patients.Building the clinical prediction rule
Comparing CWS patients with the remainder of the co-
hort, bivariate analyses identified 12 simple variables and
three combined variables significantly associated with
CWS (OR> 2.0) (Table 3). Only variables available for
external validation (Table 3) were included in the regres-
sion model. A backward-stepwise method implemented
to remove less-significant variables one by one resulted
in the retention of six significant variables that were
used to build the clinical prediction rule. The P-values,
regression coefficients, and point attributions of these
variables are shown in Table 4. The regression coeffi-
cients, which ranged from 0.5 to 1.6, were used to ex-
plore an accurate score model (points attributed for
each variable ranging from 1 to 3, total score 10 points),
but the accurate score model exhibited the same per-
formance as the simplified model presented here.
Given its stronger regression coefficient (1.64) the
variable “pain reproducible with palpation” accounted
for two points and the other variables for one point, for
a total score ranging from 0 to 7 points. The area under
the ROC curve was 0.8 (95% confidence interval 0.76-
0.83; Figure 2). We set the cut-off point at 6 points, cor-
responding to a specificity of 88.6%. Application of this
rule to the derivation cohort led to the correctTable 4 Multivariate analysis (pseudo R2: 0.2244):
P-values, regression coefficients and number of points
attributed to build the chest wall syndrome (CWS) clinical
prediction rule
Variable P-value Regression
coefficient
Number of
points attributed
for rule
Pain reproducible by palpation <0.001 1.64 2
No history of coronary
heart disease
<0.001 1.25 1
Absence of general
practitioner’s concern
0.001 1.13 1
Pain neither retrosternal
nor oppressive
0.017 0.48 1
Pain well localized (history
and/or physical examination)
0.002 0.64 1
Stabbing pain 0.041 0.50 1
Total number of points
attributable
7
CWS chest wall syndrome.
Figure 2 Receiver operating characteristic curve for the chest
wall syndrome clinical prediction rule in the derivation and
validation cohorts. AUC= area under curve.
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43 of these correctly classified CWS patients, 65 add-
itional exams (30 electrocardiograms, 16 thoracic radio-
graphies, 10 laboratory tests, eight specialist referrals,
and one thoracic computed tomography) had been pre-
scribed to reach the diagnosis. Figure 3 shows the
observed prevalence of CWS for each score value. There
were 41 false-positive patients, including three patients
with stable angina (1.8% of all positives). Classification
of each diagnostic subgroup by the CWS clinical pre-
diction rule is detailed in Table 5.
External validity
We accessed and used the Marburg database for exter-
nal validation [6]. Diagnostic classification was possible
for 1212 patients, including 565 diagnoses of CWS
(46.6%). When applied to the validation cohort, theFigure 3 Observed prevalence of chest wall syndrome (CWS) in the d
value.clinical prediction rule for CWS had an area under the
ROC curve of 0.76 (95% confidence interval 0.73-0.79),
93.4% specificity, and 22.0% sensitivity (Figure 2), corre-
sponding to a positive likelihood ratio of 3.3. Of all CWS
patients, 124 were correctly classified (22% of total;
Figure 3). There were 43 false positives, including three
patients with stable angina (1.8% of all positives). No sig-
nificant change was found after multiple imputation for
missing values of the key variable “pain reproducible by
palpation”.
Discussion
We developed a clinical prediction rule for the diagnosis
of CWS. The score ranges from 0 to 7 points, and the
cut-off was set at 6 points to obtain specificity >85%.
The rule contains the following six variables: thoracic
pain (neither retrosternal nor oppressive), stabbing pain,
well localized pain, no history of coronary heart disease,
absence of GP concern, and pain reproducible by palpa-
tion (2 points). In the derivation cohort, the area under
the curve was 0.8 and the specificity was 88.6% (319/
360). The external validation showed 93% (604/647) spe-
cificity with an area under the curve of 0.76 (95% confi-
dence interval 0.73-0.79). In addition, we observed that
the reproduction of chest pain by palpation is not path-
ognomonic of CWS.
The strengths of our study include the large numbers
of participating GPs and patients, allowing us to assume
that our sample is fairly representative. We implemented
a pragmatic strategy by consecutively including patients
through their GP practice. We achieved an excellent
follow-up at one year (96%), and more than half of the
patients lost to follow-up had an available diagnosis. Aerivation and validation cohorts for each clinical prediction rule
Table 5 Classification of other diagnosis by the chest wall
syndrome (CWS) clinical prediction rule
Diagnostic groups Classification by the CWS rule
False positive
N=41
True negative
N=476
Musculoskeletal (non-CWS) 18 23
Traumatic 14 10
Parietal metastasis 0 7
Post-thoracotomy 2 4
Arthritis/arthrosis 2 2
Cardiovascular 3 105
Stable angina 3 72
Unstable angina 0 6
Myocardial infarction 0 4
Pulmonary embolism 0 2
Arrythmia 0 10
Valvular disease 0 2
Cardiac insufficiency 0 3
Cardiomyopathy 0 1
Acute hypertension 0 5
Psychogenic 10 66
Anxious 6 48
Somatisation 4 18
Pulmonary 2 66
Infectious 2 53
Non-infectious 0 13
Digestive 3 52
Peptic affections 1 46
Non-peptic affections 2 6
Miscellaneous 5 7
Mastitis/mastalgia 4 1
Cutaneous abcess 0 1
Herpes zoster 1 1
Sarcoidosis 0 2
Chest wall keloid 0 1
Acute pyelonephritis 0 1
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which allowed us to confirm our results. However, our
study suffers several limitations. First, delayed diagnosis
was used as a reference in the absence of a panel of
experts or an independent diagnostic process. It was not
possible to perform additional tests systematically in all
patients. Second, there is currently no consensus about
the determinants or the designations of CWS in the lit-
erature. Third, there was no specific calibration for the
variable “pain reproducible with palpation,” which may
have induced differences in individual interpretations.
Fourth, some variables were not available for externalvalidation, and although they were relevant to the bivari-
ate analyses, they could not be included in the develop-
ment of the clinical prediction rule. Fifth, the two
cohorts showed design differences, what could weaken
their comparison. Only patients with acute chest pain
were included in the validation cohort; in addition, the
reference diagnosis was made by means of a telephone-
interview of the patient in the validation cohort. The
TOPIC study was not originally designed for the devel-
opment of a clinical prediction rule for CWS; if it had
been, then other diagnostic criteria may have been
explored.
Our requirement that the prediction rule be highly
specific leads, unsurprisingly, to a relatively low rate of
patients with CWS correctly classified in the derivation
cohort (127/284 = 45%). A lower rate (124/565 = 22%) in
the validation cohort can be partly explained by design
differences and semantic limits. In the derivation cohort,
the 41 false positives were not life-threatening cases;
most of these cases were easily identifiable and were
associated with a plausible pathophysiological mechan-
ism for chest pain such as trauma or thoracotomy. Inter-
estingly, parietal metastases were not classified as false
positives. However, our score misclassified three patients
(1.8% of all positives cases) with stable angina as CWS.
For these three patients, the GPs had noted symptoms
and signs for CWS as well as for cardiovascular disease,
and we therefore suspect the co-existence of both diag-
noses for these three patients. Therefore, patients with a
positive CWS clinical prediction rule in the presence of
other signs of chest pain must be carefully examined
and monitored for the final diagnosis and evolution of
chest pain.
In the literature, we found no consensus about the
classification or the determinants of CWS, and the per-
tinence of some variables is ambiguous. This lack of
clarity had already been identified [2,3,35,36]. Our study
provides a clear definition of CWS as well as a diagnos-
tic tool. Although another score has been previously
described [10], we have presented a validated tool. An-
other important difference between these two works is
the variable “absence of cough;” whereas this variable is
not relevant in our cohort, it was included in the four-
point score developed by Bösner et al. [10]. However,
since this variable is interpreted in various ways in the
literature, we believe that it is not optimal in the diagno-
sis of CWS. Finally, the reproducibility of chest pain by
palpation is addressed repeatedly in the literature. Ac-
cording to our clinical prediction rule, this variableis ne-
cessary for the diagnosis of CWS. Although this
reproducibility was previously thought to be the stron-
gest evidence of CWS [4], more recent work has demon-
strated that it is not pathognomonic of CWS [3,37,38], a
finding we have confirmed.
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tially life-threatening cause of chest pain in the emer-
gency department and in primary care practice [1,39],
and patients with CWS are referred to their GPs for fur-
ther investigation. There is a low prevalence of patients
presenting CWS in the emergency department [5], and
this disease is not followed up there. However, in ad-
dition to an emergency department triage approach, GPs
must establish the diagnosis, and will treat and follow
their patients regardless of the final diagnosis. Our clin-
ical prediction rule will aid this process. Further studies
may be necessary to verify the effectiveness of our rule
and to improve the management of CWS.
Conclusion
In conclusion, CWS is a frequent diagnosis in primary
care that is well known by general practitioners but has
been insufficiently studied in the literature. Our proposed
clinical prediction rule constitutes a tool that can be used
in addition to the usual process of diagnosing CWS by
elimination. Moreover, because its high specificity, a high
positive score may help clinicians to avoid ordering add-
itional tests. For instance, using this tool, 65additional
exams for 127 patients could have been avoided in the
derivation cohort. We propose that our clinical predic-
tion rule should be included in the clinical diagnostic
reasoning of physicians encountering a patient with chest
pain in primary care, keeping in mind that it does not ex-
clude the presence of concomitant diagnoses.
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